Trial Profile
Phase II study of sotatercept in patients with end-stage renal disease on hemodialysis- Renal Osteodystrophy
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 29 Mar 2016
Price :
$35
*
At a glance
- Drugs Sotatercept (Primary)
- Indications Renal osteodystrophy
- Focus Adverse reactions; Therapeutic Use
- 29 Mar 2016 New trial record